Jennifer A. Orange

Firm(s): 

Articles:

  • Tuesday, June 1, 2004
    In a bold move, Canada's federal government has introduced legislation, Bill C-9, that will allow Canadian generic drug manufacturers to produce patented drugs for export. The purpose of Bill C-9 is to facilitate the developing world's access to drugs in an effort to stem public health problems resulting from HIV/AIDS, tuberculosis, malaria and other...